Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.12, 2011-12, pp. : 1419-1422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine kinase: novel target in Ewing's sarcoma?

By  

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1867-1883

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL3 is a Potential Target for Breast Cancer Metastasis

By  

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 294-309

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 686-697

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite